Boothbay Fund Management, LLC Unity Biotechnology, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.5 $29,105 - $45,009	-10,002 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.15 - $6.3 $41,508 - $63,012	10,002 New	10,002 $46,000
Q1 2020 May 15, 2020	SELL	$5.0 - $7.6 $68,770 - $104,530	-13,754 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $82,386 - $115,258	13,754 New	13,754 $99,000
Q1 2019 May 15, 2019	SELL	$7.65 - $16.66 $196,635 - $428,228	-25,704 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$10.76 - $17.25 $276,575 - $443,394	25,704 New	25,704 $418,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.